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The anterior cruciate ligament (ACL) is one of five ligaments in the knee that are important for stability 
and kinematics. It is also the most commonly injured ligament of the knee and due to its poor healing 
potential, severe damage warrants surgical intervention including complete replacement. Ligaments are 
longitudinally arranged, complex tissues; the mechanical properties of ligaments are a direct result of 
their components and the arrangement of these components in the tissue. It is these mechanics that 
have made ligaments so difficult to replace. Past ACL replacements have had many limitations that 
prevented their extensive use. These limitations range from mechanical fatigue over time to fraying of 
the device after implantation. In light of these problems, investigators have begun to pursue a host of 
new techniques to create a range of viable options for the repair, replacement, and/or regeneration of 
the ACL. These options include tissue engineered scaffolds with novel designs and specially treated 
transplanted tissues. In this article, the composition, arrangement, and mechanics of the ACL will be 
discussed in order to elucidate important aspects of ACL repair and past replacements will be 
described. Afterwards, novel replacement options that look to solve problems faced by older 
replacement options will be presented. These devices use a wide variety of materials and designs to 
replicate ligament mechanics and allow for new tissue regeneration. 
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INTRODUCTION 
 
The anterior cruciate ligament (ACL) is the major intra-
articular ligament of the knee; it is also the most 
commonly injured knee ligament. Each year in the United 
States there are between 100,000 and 250,000 ACL 
injuries, or 1 in 3,000 in the general population; approxi-
mately 50,000 ligament reconstructions are performed 
annually (Cameron et al., 2000; Cooper et al., 2005; 
Miyasaka et al., 1991). The purpose of this ligament is to 
support and strengthen the knee while preventing 
extreme translation of the tibia relative to the femur. ACL 
injury is a growing problem; in a study of 17,397 people 
with 19,530 sport injuries, 37% of the patients had knee 
injuries. Of this 37%, 45.4% of these injuries involved the 
ACL with 33.9% of them requiring surgery (Majewski et 
al., 2006). A number of repair techniques are currently 
available, and the success rates for long term clinical 
outcome are 85 - 90% (Dandy, 1996; Eriksson, 1997; Fu 
and Musahl, 2001). 
The ACL is a dense, highly organized, cable-like tissue 
composed of types I, III, and V collagen, elastin, proteo-
glycans, water, and cells. Ligaments have a hierarchical 
structure with increasing levels of longitudinal organi-
zation; collagen molecules form fibrils, multiple fibrils form 
fibril bundles, and fibril bundles combine to form 
fascicles. All of these structures are arranged parallel to 
the long axis of the ligament (Laurencin and Freeman, 
2005). The collagen fibrils also display a crimp pattern, a 
periodic change in direction. In the ACL, the crimp pattern 
repeats every 45 – 60 nm (Cabaud et al., 1979; Silver, 
1994). The fascicles contain collagen fibrils, proteogly-
cans, and elastin. The ligament is surrounded by an 
epiligament sheath (Amiel et al., 1990b). The ACL also 
has antromedial and posterolateral bands and is twisted 
approximately 180° from the femoral attachment site to 
the tibial attachment site (Silver, 1994). 
The ACL is a viscoelastic tissue; its behavior is strain 
rate dependant. The combination of collagens, elastin, 
proteoglycans (such as decorin, hyaluronan, biglycan, 
fibromodulin, lumican, epiphycan and keratocan), and 
water and their arrangement in the tissue  give  ligaments  
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Figure 1. Schematic of a stress-strain curve for ligament or 
tendon displaying the toe, linear, and yield regions. 
 
 
 
their unique properties. Proteoglycans such as decorin 
organize and align the collagen fibrils during develop-
ment. The presence of large charged proteoglycans allow 
ligaments to swell with water, imparting viscoelastic 
behavior to the tissue. The arrangement of proteoglycans 
along the collagen fibrils allows the fibrils to slide by each 
other during the application of strain, leading to viscous 
dissipation of stress at low strain.  
The crimp pattern of the collagen fibers also plays a 
role in the behavior of the ACL. The presence of the 
crimp pattern allows ligaments to increase in length under 
low strains without straining the collagen molecules and 
plastically deforming the collagen fibers (Figure 1). This 
enables the tissue to respond to the presence of main-
tained stress and still recover (up to a certain amount of 
strain).  
Due to the chemistry and arrangement of their 
components, ligaments display tri-phasic behavior when 
placed under tensile loads (Figure 1). The first phase is 
the toe region, an area where the ligament exhibits a low 
amount of stress per unit strain (low slope). When force is 
first applied to the tissue it is transferred to the collagen 
fibrils, causing lateral fibrillar contraction, straightening of 
the crimp pattern, and stretching of the flexible regions of 
the collagen molecules and microfibers (Freeman and 
Silver, 2004). The next phase of tensile behavior is the 
linear region, which displays an increase in slope. Once 
the crimp pattern is straightened and flexible regions are 
stretched, the force is directly translated into collagen 
molecular strain (Diamant et al., 1972; Silver, 1994). The 
collagen triple helix is stretched and interfibrillar slippage 
occurs between crosslinks leading to an increase in 
stress per unit strain (Amiel et al., 1990a; Mosler et al., 
1985). The yield and failure region is the last phase of the 
tensile behavior. This phase begins with a slight de-
crease in slope followed by a large drop in slope due to 
tissue failure. The failure  region  represents  defibrillation 
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of the ligament (Silver, 1994), the collagen fibers in the 
ligament fail by defibrillation causing a decrease in slope 
and tissue failure (Amiel et al., 1990a; McBride et al., 
1988). In order to successfully restore the functionality of 
the knee, an ACL replacement must display the same 
biomechanical behavior as normal ACL tissue. 
 
 
TRADITIONAL ACL REPAIR OPTIONS AND PAST 
SYNTHETIC GRAFTS 
 
Traditionally, ACL injuries have been treated with 
biological based grafts (autografts or allografts) (Amiel et 
al., 1990a; Amiel et al., 1990b). Both autografts and 
allografts possess good initial mechanical strength and 
promote cell proliferation and new tissue growth. How-
ever, they suffer from a number of disadvantages. 
Autografts, tissue from the patient, inherently require 
additional surgery and which has been known to cause 
donor site morbidity, increased recovery time, and 
possible pain at the harvesting site (Cartmell and Dunn, 
2004). Autograft material for ACL repair is usually taken 
from the patient’s hamstring, patella, or quadriceps tendons. 
The patella and hamstring tendon tissues are the most 
commonly used autografts. The patella tendon graft material 
is often utilized as a “bone-patellar-bone” graft; this is 
considered the gold standard of ACL autografts. In this graft 
the tendon is removed with a piece of bone from the 
patella and from the insertion point at the tibia. It is then 
fed through a tunnel drilled through the tibia, drawn across 
the knee, and anchored into a tunnel drilled through the 
femur (Laurencin and Freeman, 2005).  
Allografts, tissues obtained from cadavers could 
potentially transmit disease, bacterial infection, and may 
elicit an unfavorable immunogenic response from the 
host (Cameron et al., 2000; Cartmell and Dunn, 2004; 
Vunjak-Novakovic et al., 2004). The benefits of using 
allografts include the lack of a second surgery for tissue 
harvest. There is also no limit to the supply of graft tissue 
as experienced with autografts. Allografts are usually 
taken from cadaveric patella tendon, hamstring tendon, 
and achilles tendon (Bell, 1995; Jackson et al., 1993).  
Many past attempts have been made to use non-
degradable, synthetic materials as ligament replace-
ments (Freeman and Kwansa, 2008). These grafts can 
be divided into the following categories: permanent 
replacements (which are not amendable to tissue 
ingrowth), augmentation devices (which protect biological 
grafts from loads during the early postoperative period), 
and scaffolds (which allow tissue ingrowth). Some of the 
non-degradable synthetic materials that have been used 
include carbon fibers, polyethylene terephthalate (PET), 
polypropylene (PP), and polytetrafluoroethylene (PTFE) 
(Amiel et al., 1990a; Amiel et al., 1990b; Arnoczky, 1983; 
Silver et al., 1991; Smith et al., 1993; Snook, 1983). 
The Leeds-Keio ligament is a woven porous tube com-
posed of PET and attached to woven tapes (Fujikawa, 
1988; Silver, 1994). This device is designed to allow the 
ingrowth of new tissue. The Kennedy Ligament  Augmen- 
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tation Device is a cylindrical PP prosthesis with a 
diamond-braided construction. This device is implanted in 
conjunction with biological grafts such as patella tendon 
tissue (Fujikawa, 1988; Silver, 1994). The Gore-Tex 
prosthesis is composed of an expanded PTFE fiber that 
is wound into loops, which are joined together to form a 
braid (Bolton and Bruchman, 1985; Olson et al., 1988).  
Although these synthetic devices initially supply the 
function of the ligaments that they replace or protect the 
ligament that they augment, these devices fail over time 
because they cannot duplicate the mechanical behavior 
of the ligament over time. Permanent replacements are 
susceptible to long-term mechanical failure due to creep 
and fatigue (Freeman and Kwansa, 2008). Augmentation 
devices may shield the biological graft from stress, which 
leads to poor long-term neoligament formation. Repeated 
elongation of these devices leads to permanent deforma-
tion at the points of stress (Freeman and Kwansa, 2008). 
Contact with sharp edges of the bone tunnel can cause 
abrasions that weaken the implant and create debris that 
can cause synovitis in the joint (Freeman and Kwansa, 
2008). Woven prostheses face the additional problems of 
axial splitting, low tissue infiltration, low extensibility, and 
abrasive wear. Eventually, these implants fail due to 
fragmentation, stress shielding of new tissue, fatigue, 
creep, and production of wear debris (Laurencin et al., 
1999; Smith et al., 1993; Woo et al., 1994). None of these 
devices have been approved by the FDA for primary ACL 
repair, but some have been approved for augmentation 
(McPherson et al., 1985).  
A successful ACL device must be designed to 
successfully support the mechanical loads experienced in 
the knee. Implanted materials will eventually fail due to 
fatigue, fragmentation, or other issues. Therefore a 
successful ACL device must be designed to promote or 
allow the growth of new tissue and degrade over time to 
prevent stress shielding. In light of these criteria and past 
device limitations a number of researchers have looked 
to tissue engineering as a new direction for ACL 
replacement and augmentation. Researchers have gone 
in a many different directions in order to develop devices 
have that fulfill each of these criteria; they vary in their 
material composition and structure. These devices can 
be classified as natural polymer based devices, synthetic 
polymer based devices, and natural tissue based 
devices.  
 
 
NATURAL POLYMER BASED DEVICES 
 
Among the materials used in biodegradable tissue-
engineered grafts are type I collagen and silk advantages 
of collagen are the capability of altering (Altman et al., 
2002;   Chen  et  al.,  2003;  Dunn  et  al.,  1995;  Dunn et 
al., 1992; Freeman and Kwansa, 2008; Vunjak-Novakovic 
et  al., 2004). Some of the resorption rate and mechanical 
properties of scaffolds through crosslinking and its low 
antigenicity. These scaffolds experience an early 
decrease  in  mechanical   strength   followed   by   tissue    
 
 
 
 
remodeling between 10 and 20 weeks with a strength 
gain similar to autografts. Fibrous proteins such as silk or 
collagen are composed mainly of specific amino acid 
sequences repeated throughout the primary structure, 
this creates homo-geneity in the protein’s secondary 
structure (collagens exhibit triple helical structures and 
most silks display -sheet conformations) (Altman et al., 
2003; Altman et al., 2002; Chen et al., 2003; Vunjak-
Novakovic et al., 2004). The rigid, extended structure of 
these proteins also gives them the mechanical properties 
necessary for the replacement of load bearing materials 
making them excellent materials for ACL replacements 
(Altman et al., 2003; Altman et al., 2002; Vunjak-
Novakovic et al., 2004). 
Dunn has studied the use of type I collagen fibers in 
potential ACL scaffolds (Altman, et al., 2002; Smith, et 
al., 1993). The grafts showed excellent biocompatibility 
and enhanced cell attachment, proliferation, and pro-
duction of extracellular matrix. Unfortunately this scaffold 
did not fare well mechanically; the collagen scaffold is 
made from type I collagen fibers arranged in parallel 
(other scaffolds have been made with synthetic polymers 
coated with a collagen solution). Groups of aligned fibers 
lack structural reinforcement and do not prevent fatigue. 
The arrangement of the fibers in parallel with the direction 
of stress may cause long-term failure due to fatigue, 
creep, and abrasive wear. 
Another natural polymer based tissue engineered 
structure is a matrix composed of twisted silk fibers 
developed by Altman et al. (2002), Chen et al. (2003), 
Vunjak-Novakovic et al. (2004). This structure combines 
the use of a three-dimensional, porous matrix with the 
use of isolated cells that have been allowed to proliferate 
in vitro. This matrix is a hierarchical structure where 
bundles of silk fibers are wound into strands that are 
wound into cords and arranged to form the matrix. This 
arrangement is similar to that of collagen fibers in 
ligaments and tendons. In these tissues collagen fibers 
arranged to form fascicles and the fascicles join to form 
the ligament (Silver et al., 2003).  
Biocompatibility tests with bone marrow stromal cells 
(BMSCs) show that the silk matrix is not cytotoxic 
(Altman et al., 2002; Chen et al., 2003; Vunjak-Novakovic 
et al., 2004). The twisted fiber architecture gives the 
scaffold mechanical properties that are similar to ACL. As 
the matrix is subjected to tensile load the twisting pattern 
straightens, creating a toe region; this is followed by a 
linear region. This behavior is important for the preven-
tion of damage due to fatigue and creep. The matrices 
have a maximum load of 2337 ± 72 N, strain at failure of 
38.6 ± 2.4%, and elastic modulus of 354 ± 26 N/mm, 
which are similar to ACL. The biocompatibility and ability of 
these matrices to elicit new tissue growth can been 
increased by coating the surface with RGD sequences 
(Chen et al., 2003). The addition of RGD sequences has 
been shown to increase cellular attachment and 
proliferation. The presence of the RGD sequences on the 
silk fibers also  increased  extracellular  matrix  (ECM)  by  
 
 
 
 
BMSCs which could lead to faster tissue regeneration. 
 
 
SYNTHETIC POLYMER BASED DEVICES 
 
In recent years, a variety of different materials and struc-
tures have been investigated for use in tissue engineered 
ligament replacements. Most of these are synthetic, 
biodegradable polymers; they include poly glycolic acid 
(PGA), poly lactic acid (PLA), their copolymers, 
polyurethane urea (PUU) (Bourke, et al., 2004), poly 
desaminotyrosyl-tyrosine ethyl carbonate (poly (DTE 
carbonate)), polydioxanone (PDS) and poly caprolactone 
(PCL) (Bourke et al., 2004; Freeman and Kwansa, 2008; 
Laurencin and Freeman, 2005). The use of synthetic 
biodegradable polymers has several benefits. There is no 
limit to the supply of grafts (as opposed to autografts) and 
there is no risk of disease transmission. These polymers 
are designed to degrade over time and therefore do not 
cause a long term foreign body response. The 
mechanical properties of the device may also be 
controlled by altering the degree of polymer crystallinity, 
changing the polymer molecular weight, or changing the 
ratio of each polymer in the copolymer. 
A poly (DTE carbonate) scaffold developed by the 
groups of Dunn and Kohn has shown the ability to 
support fibroblast growth and display the necessary 
strength for use as an ACL graft (Bourke et al., 2004). 
The use of PDS as a potential material for scaffold 
construction has been slowed. Investigations have shown 
that the rapid loss of its mechanical strength due to 
degradation makes it a poor choice for use in ligament 
tissue engineering (Buma et al., 2004). Once again, 
structure is a potential flaw in many of these matrices. 
The (poly (DTE carbonate)) and other PUU grafts were 
composed of polymeric structures arranged in parallel. 
The poly (DTE carbonate) matrix is made of parallel 
fibers and the PUU structure is a woven band. These 
designs may lead to sudden failure due to lack of struc-
tural reinforcement. The arrangement of fibers in parallel 
with the direction of stress may cause fatigue and creep. 
Laurencin and his colleagues have developed a tissue 
engineered scaffold based on a cell seeded, degradable, 
three-dimensional (3-D) braided, poly L-lactic acid (PLLA) 
scaffold (Cooper et al., 2007; Cooper et al., 2005; Lu et 
al., 2005). PLLA is a degradable polymer which allows 
load to gradually shift from the implant to the neoligament 
over time. This scaffold uses 3-D braiding techniques to 
create a scaffold with controlled pore size, well integrated 
pores, resistance to wear and rupture, and mechanical 
properties comparable to the ACL. The fibers in the 3-D 
braiding technique all reinforce one another increasing 
scaffold strength. The control of pore size and integration 
of pores are important for the distribution of nutrients 
throughout the scaffold, removal of waste from the 
scaffold, cell motility, and the development of new tissue 
throughout the scaffold. This braided scaffold also has a 
hierarchical structure similar to the ligament. It is com- 
posed  of  PLLA  fibers  (similar  in  diameter  to  collagen  
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fibers) which are arranged into bundles and woven 
throughout the scaffold thickness. 
In the past there have been woven or braided ligament 
replacement structures which performed well in the short 
term after implantation, but the long-term outcomes of 
these prostheses have been poor (Arnoczky, 1983; Silver 
et al., 1991). These braids were limited by poor tissue 
integration, poor abrasion resistance, and fatigue 
(Konikoff et al., 1974; Yahia, 1997). The 3-D braided 
scaffolds have three regions: a femoral tunnel attachment 
site (bony attachment end), a ligament region (intra-
articular zone), and tibial tunnel attachment site (bony 
attachment end). The attachment sites have a higher 
fiber braiding angle than the intra-articular zone. These 
angle differences cause changes in pore size between 
the areas. Studies have shown that a minimum pore 
diameter of 150 µm is necessary for bone growth into 
scaffolds and 200 – 250 m for soft tissue ingrowth 
(Konikoff et al., 1974; Yahia, 1997). The different regions 
of the scaffold contain pore sizes within these ranges to 
encourage tissue (ligament and bone) ingrowth and 
capillary supply. The higher braiding angle at the inser-
tion points also provides resistance to wear within bone 
tunnels, and improves the integration of bone tissue. The 
pore interconnectivity extending through the implant 
increases the overall surface area for cell attachment, 
allowing tissue ingrowth into the interior of the scaffold. 
In in vivo studies with this scaffold implanted into the 
knees of adult New Zealand white rabbits, the rabbits 
were weight-bearing within 24 h after surgery (a display 
of the scaffold’s strength) (Cooper, 2002; Cooper et al., 
2007). After 12 weeks of implantation in the knees of 
adult New Zealand white rabbits, cell seeded scaffolds 
displayed signs of developing new ACLs. The scaffolds 
were completely infiltrated by cells and dense connective 
tissue. The newly synthesized collagen displayed a crimp 
pattern and was bonded to the PLLA filaments. Histolo-
gical studies showed the presence of neovasculature in 
the developing ligament.  
Another recent design is the braid-twist scaffold 
(Freeman et al., 2008; Freeman et al., 2007). It combines 
two techniques (fiber braiding and fiber twisting) that are 
commonly used in textiles and have been used 
separately in previous ligament prostheses. Braiding is a 
technique that has been used to create products 
designed to bear axial loads and provide mechanical 
reinforcement (Kawabata, 1989). Braided structures are 
shear resistant, conformable, and can transfer large 
loads while provide extension (Cooper, 2002). 
The twisting of fibers is used in the textile industry to 
form yarns (Joseph et al., 1993). The twisting direction 
and degree of twisting affect yarn strength, abrasion 
resistance, and flexibility. A low degree of twist produces 
weaker yarns that pull apart more easily and can develop 
protrusions on their surfaces from abrasions. Increasing the 
amount of twist improves yarn strength and abrasion 
resistance. Although if the yarns are wound too tightly 
(and the fibers become increasingly perpendicular  to  the 
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long axis of the yarn), the strength and abrasion resis-
tance decrease (Joseph et al., 1993). Combining fiber 
twisting with fiber braiding yields a mechanically stable 
structure with a larger load capacity and greater degree 
of extensibility. The degree of braiding or twisting can be 
altered in order to match the device mechanics with the 
mechanics of the tissue being replaced (Freeman et al., 
2007). 
The structure of this scaffold is also similar to the 
organization of a native ligament and is designed to 
mimic the biomechanical behavior of the ACL (display a 
toe region and linear region when placed under 
increasing load). It is composed PLLA fibers (which are 
bundles of microfibers, approximately 20 µm in diameter), 
a degradable poly -hydroxyester that has been 
approved by the FDA for implantation in other biomedical 
devices (Freeman et al., 2008; Freeman et al., 2007). In 
previous studies, the braid-twist scaffold with the best 
degree of twisting and braiding had an ultimate tensile 
stress (UTS) of 81.6 ± 1.6 MPa, elastic modulus of 
approximately 750 MPa, toe region length of 4%, and 
strain at failure of 30% (Freeman et al., 2007). The UTS 
for human ACL has been measured at 38 ± 9 MPa, which 
is lower than the UTS of the braid-twist scaffold (Freeman 
et al., 2007; Pioletti et al., 1999). Mechanical tests on 
human ligaments have yielded various elastic moduli 
values, 65 to 111 MPa (Silver, 1994), 180 ± 25 MPa, and 
242 ± 28 MPa (Dienst et al., 2002). Previous studies 
indicate that human ligaments have toe regions that 
range from 2.0 to 4.8% (Ambrosio et al., 1998; Bonifasi-
Lista et al., 2005; Dienst et al., 2002; Moon et al., 2006; 
Thornton et al., 2002). Higher UTS and modulus values 
may be necessary to allow the device to degrade while 
still bearing the appropriate amount of load. 
Stress relaxation tests on these scaffolds show that the 
braid-twist scaffolds have a rapid decrease in stress 
followed by a plateau region, similar to natural ligament 
tissue (Freeman et al., 2008). Unfortunately the final 
relative stresses (0.873 and 0.829) were higher than 
those seen in ACL and posterior cruciate ligament (PCL) 
(0.63 and 0.75) (Freeman et al., 2008; Pioletti and 
Rakotomanana, 2000; Pioletti et al., 1999). Mathematical 
modeling of the viscoelastic behavior demonstrates that 
the stress relaxation behavior can be changed by altering 
the braiding angles and twisting angles (Freeman et al., 
2008).  
These scaffolds were also evaluated for their ability to 
sponsor fibroblast proliferation (Freeman et al., 2008). 
The scaffolds displayed the ability to sponsor the growth 
of patella tendon fibroblasts. The results of MTS assays 
showed an increase in the number of viable cells over 28 
days. Scanning electron microscope images also showed 
the presence of ECM material secreted by the cells onto 
the braid-twist scaffolds (Freeman et al., 2008). 
 
 
BIOLOGICAL TISSUE BASED DEVICES 
 
Concerns with devices produced from biological tissues  
 
 
 
 
are usually based on the source of the material, when 
using tissues from a source other than the patient. These 
concerns include the potential of bacterial infection, 
disease transmission, or unfavorable immunogenic 
response (Konikoff et al., 1974; Laurencin and Freeman, 
2005). Some sterilization methods for these tissues can 
weaken their mechanical properties. On the other hand, 
they do not require a second harvest surgery, as in 
autografts. There is a virtually unlimited supply of graft 
tissue for these devices and they have the appropriate 
initial mechanical strength (depending on the tissue 
source) (Konikoff et al., 1974). They also promote cell 
proliferation and new tissue growth. 
Xenografts (tissues from animals) have been presented 
as an option for ACL repair. These tissues have the same 
advantages and disadvantages as allografts, but they 
may also carry the additional risk of transferring a 
disease seen in animal populations to a human host. 
Rejection of the foreign tissue is another very serious risk 
of xenografts. Recent work by Stone et al. (2007) has 
looked to reduce these risks; they have shown that 
specially pretreated xenografts are viable options for 
tissue repair, including the ACL (Freeman and Kwansa, 
2008; Kainer et al., 2004; Laurencin and Freeman, 2005; 
Stone et al., 2007; Stone et al., 1997; Stone et al., 2007; 
Yahia, 1997). Stone and colleagues have utilized 
chemically modified grafts from cloned pigs as ACL 
replacements. In preparation for implantation, the porcine 
graft material is immunochemically modified and 
chemically crosslinked (Kainer et al., 2004; Laurencin 
and Freeman, 2005; Phelps et al., 2003; Stone et al., 
2007; Stone et al., 1997; Stone et al., 2007; Yahia, 1997). 
The immunochemical modification involves the enzy-
matic removal of the the -gal epitopes in order to 
prevent graft rejection. This process eliminates the 
interaction between the natural anti-Gal antibody and -
gal epitopes. This interaction has been a major obstacle 
in the use of porcine tissues in humans (Stone et al., 
1997; Stone et al., 2007). Recently, the cloning of pigs 
lacking -gal epitopes has eliminated this obstacle (Galili, 
1993; Stone et al., 2007).  In addition, the ACL grafts 
used in these studies have been pulse lavaged to remove 
cellular components further reducing the risk of rejection. 
The grafts have also been crosslinked with 0.10% 
gluteraldehyde for 12 h followed by glycine endcapping to 
block unreacted gluteraldehyde molecules and steriliza-
tion by electron beam irradiation at 17.8 kGy (Stone et 
al., 1998; Stone et al., 2007). These steps increase 
mechanical strength and sterilize the graft respectively. 
In an in vivo study, 20 rhesus monkeys were recon-
structed with treated porcine grafts for 2, 6, and 12 
months; 3 monkeys were used at the 2 month time point, 
5 monkeys were used at the 6 month time point and 
another 5 monkeys were used at the 12 month time point 
(Stone et al., 2007). The controls consisted of 1 untreated 
porcine allograft and 1 rhesus allograft at 2 months along 
with 5 rhesus allografts at 12 months. Graft material 
consisted   of   treated  porcine  bone–patellar  tendon–bone  
 
 
 
 
grafts and fresh frozen rhesus bone–patellar tendon–
bone grafts. The devices for implantation were 30 mm 
long by 4 mm wide (tendon material) grafts with bone 
plug ends of 5 mm diameter by 7 mm in length. The 
grafts and corresponding intact ligaments from the 
opposite leg were mechanically tested at 6 and 12 
months. The mechanical testing was followed by histolo-
gical examination of extracted grafts.  
The implants promoted the regeneration of new 
ligament tissue (Stone et al., 2007) with signs of graft 
remodeling extending from the periphery of the graft to its 
center. In addition, after 12 months the porcine grafts 
displayed comparable ultimate load, yield load, stiffness 
and ultimate displacement to monkey grafts. The strength 
of the implanted treated grafts increased from 43 to 58% 
between 6 and 12 months. The grafts also demonstrated 
lower values for ultimate strength, yield strength, ultimate 
strain, and modulus compared to intact ligaments (Stone 
et al., 2007). 
The animals were tested for signs of porcine graft 
rejection (Stone et al., 1998). Blood samples were taken 
prior to surgery and after surgery, at days 10, 14, 21, 28, 
42, 56 as well as at 3, 6, 9, and 12 months. Blood 
samples were analyzed for the presence of anti-Gal and 
anti–non-Gal antibodies, including antibodies to proteins 
present in the porcine grafts. Serum immunoglobulin (Ig) 
anti-Gal IgG and IgM activity was determined by ELISA. 
The analysis showed a greater increase in anti-Gal titers 
(>200%) in animals with the untreated porcine graft when 
compared to animals with the treated graft (95% lower 
than the untreated) within 2 weeks following implantation. 
The response to the untreated grafts indicates acute 
rejection which may lead to graft destruction and 
resorption. It is hypothesized that the smaller increase in 
anti-Gal titers in animals with the treated grafts may be 
due to an immune response not to -gal epitopes on the 
graft itself, but those on the porcine bone marrow cells in 
cancellous bone of the bone-ligament-bone graft. The 
anti-Gal titers reached resolved preimplantation values by 
8 to 12 weeks after implantation.  
In an additional clinical study by Stone et al. (2007), 
these porcine grafts were implanted into human subjects 
for ACL replacement. Western blotting analysis and 
ELISA showed the presence of anti-non-gal antibodies 
against multiple pig xenoproteins in the grafts. The 
antibody levels peaked from 2 to 6 months, but the 
antibodies were no longer produced 2 years after 
implantation. No antibodies were produced against 
human ligament proteins. After 2 years, 5 of the 6 
patients displayed no problem with the function of the 
porcine graft. 
 
 
CONCLUSION 
 
As the number of incidents of ACL injury increases in 
increasingly younger populations, additional options for 
ligament repair that  overcome  the  limitations  of  current  
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treatments are necessary. The ACL is a complex, highly 
ordered tissue with mechanical properties that are impor-
tant for normal knee kinematics. These new options must 
display the mechanics of the original ligament while 
sponsoring the growth of new tissue and resisting 
rejection from the body. In response to these criteria, 
researchers are turning to a variety of techniques and 
material sources. Solutions in this new generation of ACL 
grafts typically fall into one of three categories, natural 
materials based devices, synthetic materials based 
devices, and natural tissue based devices. Candidates 
from each of these categories have a number of benefits 
and have achieved degrees of success in ACL replace-
ment and regeneration. The devices listed above 
represent some of the advancements that have been 
made in ACL tissue engineering in each of these 
categories. These devices have been designed to fulfill 
the needs of a tissue engineered replacements for 
musculoskeletal tissues; these include structural stability, 
appropriate mechanical strength, promotion of cell and 
tissue growth, and the ability to slowly degrade and allow 
the new tissue to bear the load. As research into ACL 
replacement and regeneration continues, it is expected 
that tissue engineering techniques will lead the way in the 
design, production, and testing of next generation 
scaffolds to will mimic the mechanics of natural ligament 
and lead to the quick and complete regeneration of a 
new, mechanically sound, natural tissue. 
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